CASE DISCUSSION
Retinopathy diabetes- An overview
Presented India by Dr. Swathi PanbudeViews
26,583
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Diabetic retinopathy is the leading cause of visual loss in western adults of working age. Among diabetes mellitus microvascular complications, this is the most common. When the retina is damaged to the point of threatening vision, diabetic retinopathy can cause blindness. People with diabetes can...
Case Summary
- The session began with a discussion on diabetic retinopathy, highlighting its rising prevalence in India, where approximately one-third of the 80 million diagnosed diabetics are at risk. The condition's development hinges on factors like diabetes duration, glycemic control, and the presence of hypertension, hypolipidemia, smoking, nephropathy, neuropathy, or cardiovascular diseases. Notably, a 2013 survey ranked diabetic retinopathy as the fifth leading cause of vision loss globally among diabetics.
Speaker Profile
Dr. Swathi Panbude
Assistant Professor, Biochemistry, Datta Megha Institute of Medical Sciences, WardhaDr. Swathi Panbude is an Assistant Professor in the Department of Biochemistry at Datta Megha Institute of Medical Sciences, Wardha. She is involved in undergraduate and postgraduate teaching with a strong focus on clinical biochemistry and medical education. Her academic interests include metabolic disorders, laboratory diagnostics, and applied biochemistry in clinical practice. She actively contributes to research, student training, and curriculum development in medical biochemistry. Through her academic role, she supports the advancement of foundational medical sciences and evidence-based learning.
Disclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.